You are here

Article info

Article menu

Download PDFPDF

Therapeutics/Prevention
Systematic review with meta analysis
With statin co-administration, drugs designed to increase HDL have no impact on cardiovascular outcomes
Free

Authors

  1. Correspondence to : Professor Paul N Durrington, Cardiovascular Research Group, University of Manchester, Core Technology Facility, 46 Grafton Street, Manchester M13 9NT, UK; pdurrington{at}manchester.ac.uk
View Full Text

Citation

Durrington PN
With statin co-administration, drugs designed to increase HDL have no impact on cardiovascular outcomes
BMJ Evidence-Based Medicine 2015;20:12.

Publication history

  • First published September 23, 2014.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions